Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Comparative safety and efficacy of percutaneous approaches for the treatment of trigeminal neuralgia: A systematic review and meta-analysis.

Texakalidis P, Xenos D, Tora MS, Wetzel JS, Boulis NM.

Clin Neurol Neurosurg. 2019 Jul;182:112-122. doi: 10.1016/j.clineuro.2019.05.011. Epub 2019 May 14. Review.

PMID:
31121470
2.

Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.

Mazzini L, Gelati M, Profico DC, Sorarù G, Ferrari D, Copetti M, Muzi G, Ricciolini C, Carletti S, Giorgi C, Spera C, Frondizi D, Masiero S, Stecco A, Cisari C, Bersano E, De Marchi F, Sarnelli MF, Querin G, Cantello R, Petruzzelli F, Maglione A, Zalfa C, Binda E, Visioli A, Trombetta D, Torres B, Bernardini L, Gaiani A, Massara M, Paolucci S, Boulis NM, Vescovi AL; ALS-NSCs Trial Study Group.

Stem Cells Transl Med. 2019 May 18. doi: 10.1002/sctm.18-0154. [Epub ahead of print]

3.

Recovery of shoulder abduction in traumatic brachial plexus palsy: a systematic review and meta-analysis of nerve transfer versus nerve graft.

Hardcastle N, Texakalidis P, Nagarajan P, Tora MS, Boulis NM.

Neurosurg Rev. 2019 Apr 17. doi: 10.1007/s10143-019-01100-9. [Epub ahead of print] Review.

PMID:
30997618
4.

Neurosurgeons' Armamentarium for the Management of Refractory Postherpetic Neuralgia: A Systematic Literature Review.

Texakalidis P, Tora MS, Boulis NM.

Stereotact Funct Neurosurg. 2019;97(1):55-65. doi: 10.1159/000499476. Epub 2019 Apr 17. Review.

5.

Percutaneous Trigeminal Nerve Stimulation for Persistent Idiopathic Facial Pain: A Case Series.

McMahon JT, Tora MS, Bentley JN, Texakalidis P, Campbell MA, Keifer OP Jr, Boulis NM.

World Neurosurg. 2019 Mar 20. pii: S1878-8750(19)30775-2. doi: 10.1016/j.wneu.2019.03.107. [Epub ahead of print]

PMID:
30902776
6.

Combined Radial to Axillary and Spinal Accessory Nerve (SAN) to Suprascapular Nerve (SSN) Transfers May Confer Superior Shoulder Abduction Compared with Single SA to SSN Transfer.

Texakalidis P, Tora MS, Lamanna JJ, Wetzel J, Boulis NM.

World Neurosurg. 2019 Mar 18. pii: S1878-8750(19)30736-3. doi: 10.1016/j.wneu.2019.03.075. [Epub ahead of print]

PMID:
30898759
7.

Supraorbital Occipital Circumferential Stimulation for the Treatment of Refractory Chronic Primary Headache: A Case Series.

Jiang JF, Diaz AN, Campbell M, Boulis NM, Keifer OP Jr.

World Neurosurg. 2019 Jan 3. pii: S1878-8750(18)32931-0. doi: 10.1016/j.wneu.2018.12.108. [Epub ahead of print]

PMID:
30610973
8.

Phantom Sensation-Underreported Sensory Outcome Following Intercostal-to-Musculocutaneous Nerve Transfer.

Mlaver E, Keifer O Jr, Tora MS, Campbell M, Boulis NM.

World Neurosurg. 2019 Feb;122:303-307. doi: 10.1016/j.wneu.2018.10.216. Epub 2018 Nov 9.

PMID:
30415052
9.

Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses.

Donsante A, Boulis NM.

Expert Opin Biol Ther. 2018 Jul;18(7):755-764. doi: 10.1080/14712598.2018.1492544. Epub 2018 Jul 2. Review.

PMID:
29936867
10.

Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.

Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges L, Patil PG, Sakowski SA, Feldman EL.

Ann Clin Transl Neurol. 2018 May 2;5(6):730-740. doi: 10.1002/acn3.567. eCollection 2018 Jun.

11.

AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials.

Hardcastle N, Boulis NM, Federici T.

Expert Opin Biol Ther. 2018 Mar;18(3):293-307. doi: 10.1080/14712598.2018.1416089. Epub 2017 Dec 18. Review.

PMID:
29249183
12.

SpinoBot: An MRI-Guided Needle Positioning System for Spinal Cellular Therapeutics.

Squires A, Oshinski JN, Boulis NM, Tse ZTH.

Ann Biomed Eng. 2018 Mar;46(3):475-487. doi: 10.1007/s10439-017-1960-z. Epub 2017 Nov 17.

PMID:
29150766
13.

Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord.

Lamanna JJ, Gutierrez J, Espinosa JR, Wagner J, Urquia LN, Moreton C, Victor Hurtig C, Tora M, Kirk AD, Federici T, Boulis NM.

J Clin Neurosci. 2018 Feb;48:173-180. doi: 10.1016/j.jocn.2017.10.033. Epub 2017 Oct 28.

PMID:
29089163
14.

Occipital Nerve Stimulation for the Treatment of Refractory Occipital Neuralgia: A Case Series.

Keifer OP Jr, Diaz A, Campbell M, Bezchlibnyk YB, Boulis NM.

World Neurosurg. 2017 Sep;105:599-604. doi: 10.1016/j.wneu.2017.06.064. Epub 2017 Jun 17.

PMID:
28634063
15.

Differentiation of Bone Marrow Stem Cells into Schwann Cells for the Promotion of Neurite Outgrowth on Electrospun Fibers.

Xue J, Yang J, O'Connor DM, Zhu C, Huo D, Boulis NM, Xia Y.

ACS Appl Mater Interfaces. 2017 Apr 12;9(14):12299-12310. doi: 10.1021/acsami.7b00882. Epub 2017 Mar 30.

16.

Ferumoxytol Labeling of Human Neural Progenitor Cells for Diagnostic Cellular Tracking in the Porcine Spinal Cord with Magnetic Resonance Imaging.

Lamanna JJ, Gutierrez J, Urquia LN, Hurtig CV, Amador E, Grin N, Svendsen CN, Federici T, Oshinski JN, Boulis NM.

Stem Cells Transl Med. 2017 Jan;6(1):139-150. doi: 10.5966/sctm.2015-0422. Epub 2016 Aug 29.

17.

The challenges of developing a gene therapy for amyotrophic lateral sclerosis.

Tora MS, Keifer OP Jr, Lamanna JJ, Boulis NM.

Expert Rev Neurother. 2017 Apr;17(4):323-325. doi: 10.1080/14737175.2017.1287565. Epub 2017 Feb 22. No abstract available.

PMID:
28132569
18.

Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord.

Lamanna JJ, Urquia LN, Hurtig CV, Gutierrez J, Anderson C, Piferi P, Federici T, Oshinski JN, Boulis NM.

Stereotact Funct Neurosurg. 2017;95(1):60-68. doi: 10.1159/000448765. Epub 2017 Jan 28.

19.

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

Atassi N, Beghi E, Blanquer M, Boulis NM, Cantello R, Caponnetto C, Chiò A, Dunnett SB, Feldman EL, Vescovi A, Mazzini L; attendees of the International Workshop on Progress in Stem Cells Research for ALS/MND.

Cytotherapy. 2016 Dec;18(12):1471-1475. doi: 10.1016/j.jcyt.2016.08.005. Epub 2016 Oct 6.

20.

Gene, Stem Cell, and Alternative Therapies for SCA 1.

Wagner JL, O'Connor DM, Donsante A, Boulis NM.

Front Mol Neurosci. 2016 Aug 12;9:67. doi: 10.3389/fnmol.2016.00067. eCollection 2016. Review.

21.

Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.

Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, Goutman SA, Feldman EL.

Neurology. 2016 Jul 26;87(4):392-400. doi: 10.1212/WNL.0000000000002889. Epub 2016 Jun 29. Erratum in: Neurology. 2017 Aug 1;89(5):521.

22.

Erratum to 'Gene therapy for neurodegenerative diseases' [Trends in Molecular Medicine 21 (2015) 504-512].

O'Connor DM, Boulis NM.

Trends Mol Med. 2016 Mar;22(3):266. doi: 10.1016/j.molmed.2015.12.008. Epub 2016 Jan 23. No abstract available.

PMID:
29496034
23.

Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain.

Donsante A, McEachin Z, Riley J, Leung CH, Kanz L, O'Connor DM, Boulis NM.

Gene Ther. 2016 May;23(5):401-7. doi: 10.1038/gt.2016.6. Epub 2016 Jan 29.

PMID:
26824881
24.

β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS).

Bartus RT, Bétourné A, Basile A, Peterson BL, Glass J, Boulis NM.

Neurobiol Dis. 2016 Jan;85:11-24. doi: 10.1016/j.nbd.2015.10.006. Epub 2015 Oct 14. Review.

25.

Preclinical Validation of Multilevel Intraparenchymal Stem Cell Therapy in the Porcine Spinal Cord.

Gutierrez J, Lamanna JJ, Grin N, Hurtig CV, Miller JH, Riley J, Urquia L, Avalos P, Svendsen CN, Federici T, Boulis NM.

Neurosurgery. 2015 Oct;77(4):604-12; discussion 612. doi: 10.1227/NEU.0000000000000882.

PMID:
26134596
26.

Gene therapy for neurodegenerative diseases.

O'Connor DM, Boulis NM.

Trends Mol Med. 2015 Aug;21(8):504-12. doi: 10.1016/j.molmed.2015.06.001. Epub 2015 Jun 26. Review. Erratum in: Trends Mol Med. 2016 Mar;22(3):266. Trends Mol Med. 2016 Mar;22(3):266.

PMID:
26122838
27.

Human neural stem cell transplantation in ALS: initial results from a phase I trial.

Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, Ricciolini C, Rota Nodari L, Carletti S, Giorgi C, Spera C, Domenico F, Bersano E, Petruzzelli F, Cisari C, Maglione A, Sarnelli MF, Stecco A, Querin G, Masiero S, Cantello R, Ferrari D, Zalfa C, Binda E, Visioli A, Trombetta D, Novelli A, Torres B, Bernardini L, Carriero A, Prandi P, Servo S, Cerino A, Cima V, Gaiani A, Nasuelli N, Massara M, Glass J, Sorarù G, Boulis NM, Vescovi AL.

J Transl Med. 2015 Jan 27;13:17. doi: 10.1186/s12967-014-0371-2.

28.

Rational design and engineering of a modified adeno-associated virus (AAV1)-based vector system for enhanced retrograde gene delivery.

Davis AS, Federici T, Ray WC, Boulis NM, OʼConnor D, Clark KR, Bartlett JS.

Neurosurgery. 2015 Feb;76(2):216-25; discussion 225. doi: 10.1227/NEU.0000000000000589.

PMID:
25549186
29.

Deep brain stimulation for chronic pain: intracranial targets, clinical outcomes, and trial design considerations.

Keifer OP Jr, Riley JP, Boulis NM.

Neurosurg Clin N Am. 2014 Oct;25(4):671-92. doi: 10.1016/j.nec.2014.07.009. Review.

30.

Introduction to neuropathic pain syndromes.

Gutierrez J, Raju S, Riley JP, Boulis NM.

Neurosurg Clin N Am. 2014 Oct;25(4):639-62. doi: 10.1016/j.nec.2014.06.002. Epub 2014 Aug 5. Review.

PMID:
25240654
31.

Vesicle associated membrane protein 8 (VAMP8)-mediated zymogen granule exocytosis is dependent on endosomal trafficking via the constitutive-like secretory pathway.

Messenger SW, Falkowski MA, Thomas DD, Jones EK, Hong W, Gaisano HY, Boulis NM, Groblewski GE.

J Biol Chem. 2014 Oct 3;289(40):28040-53. doi: 10.1074/jbc.M114.593913. Epub 2014 Aug 19. Erratum in: J Biol Chem. 2014 Dec 19;289(51):35264. Giasano, Herbert Y [Corrected to Gaisano, Herbert Y].

32.

Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.

Passini MA, Bu J, Richards AM, Treleaven CM, Sullivan JA, O'Riordan CR, Scaria A, Kells AP, Samaranch L, San Sebastian W, Federici T, Fiandaca MS, Boulis NM, Bankiewicz KS, Shihabuddin LS, Cheng SH.

Hum Gene Ther. 2014 Jul;25(7):619-30. doi: 10.1089/hum.2014.011. Epub 2014 Apr 28.

PMID:
24617515
33.

Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.

Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD.

Ann Neurol. 2014 Mar;75(3):363-73. doi: 10.1002/ana.24113. Epub 2014 Mar 7.

34.

Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application.

Lamanna JJ, Miller JH, Riley JP, Hurtig CV, Boulis NM.

Ther Deliv. 2013 Nov;4(11):1397-410. doi: 10.4155/tde.13.111.

PMID:
24228990
35.

Gene and protein therapies utilizing VEGF for ALS.

Keifer OP Jr, O'Connor DM, Boulis NM.

Pharmacol Ther. 2014 Mar;141(3):261-71. doi: 10.1016/j.pharmthera.2013.10.009. Epub 2013 Oct 29. Review.

36.

Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes.

Riley J, Glass J, Feldman EL, Polak M, Bordeau J, Federici T, Johe K, Boulis NM.

Neurosurgery. 2014 Jan;74(1):77-87. doi: 10.1227/NEU.0000000000000156.

PMID:
24018694
37.

Progress in gene therapy for neurological disorders.

Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, Gray SJ, Lowenstein PR, Vandenberghe LH, Wilson TJ, Wolfe JH, Glorioso JC.

Nat Rev Neurol. 2013 May;9(5):277-91. doi: 10.1038/nrneurol.2013.56. Epub 2013 Apr 23. Review. Erratum in: Nat Rev Neurol. 2013 Jun;9(6):298.

38.

Regulated neuronal neuromodulation via spinal cord expression of the gene for the inwardly rectifying potassium channel 2.1 (Kir2.1).

Boulis NM, Handy CR, Krudy CA, Donnelly EM, Federici T, Franz CK, Barrow EM, Teng Q, Kumar P, Cress D.

Neurosurgery. 2013 Apr;72(4):653-61; discussion 661. doi: 10.1227/NEU.0b013e318283f59a.

PMID:
23277370
39.

Surgical technique for spinal cord delivery of therapies: demonstration of procedure in gottingen minipigs.

Federici T, Hurtig CV, Burks KL, Riley JP, Krishna V, Miller BA, Sribnick EA, Miller JH, Grin N, Lamanna JJ, Boulis NM.

J Vis Exp. 2012 Dec 7;(70):e4371. doi: 10.3791/4371.

40.

An overview of domestic and international clinical trials for delivery of cellular therapies to the spinal cord.

Riley J, Taub J, Raore B, Boulis NM.

Clin Neurosurg. 2012;59:98-104. Review. No abstract available.

PMID:
22960520
41.

Update on gene and stem cell therapy approaches for spinal muscular atrophy.

Donnelly EM, Boulis NM.

Expert Opin Biol Ther. 2012 Nov;12(11):1463-71. doi: 10.1517/14712598.2012.711306. Epub 2012 Jul 31. Review.

PMID:
22849423
42.

Stem cell therapy for the spinal cord.

Donnelly EM, Lamanna J, Boulis NM.

Stem Cell Res Ther. 2012 Jul 9;3(4):24. doi: 10.1186/scrt115. Review.

43.

Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.

O'Connor DM, Boulis NM.

Neurosci Lett. 2012 Oct 11;527(2):78-84. doi: 10.1016/j.neulet.2012.04.079. Epub 2012 May 8. Review.

PMID:
22579818
44.

Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.

Riley J, Federici T, Polak M, Kelly C, Glass J, Raore B, Taub J, Kesner V, Feldman EL, Boulis NM.

Neurosurgery. 2012 Aug;71(2):405-16; discussion 416. doi: 10.1227/NEU.0b013e31825ca05f.

PMID:
22565043
45.

Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.

Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, Kelly C, Feldman EL.

Stem Cells. 2012 Jun;30(6):1144-51. doi: 10.1002/stem.1079.

46.

Characterization of a murine model of SMA.

Donnelly EM, Quach ET, Hillery TM, Heeke BL, Snyder BR, Handy CR, O'Connor DM, Boulis NM, Federici T.

Neurobiol Dis. 2012 Mar;45(3):992-8. doi: 10.1016/j.nbd.2011.12.018. Epub 2011 Dec 14.

PMID:
22198571
47.

Translational stem cell therapy for amyotrophic lateral sclerosis.

Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL.

Nat Rev Neurol. 2011 Dec 13;8(3):172-6. doi: 10.1038/nrneurol.2011.191. Review.

PMID:
22158518
48.

Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs.

Federici T, Taub JS, Baum GR, Gray SJ, Grieger JC, Matthews KA, Handy CR, Passini MA, Samulski RJ, Boulis NM.

Gene Ther. 2012 Aug;19(8):852-9. doi: 10.1038/gt.2011.130. Epub 2011 Sep 15.

PMID:
21918551
49.

Gene therapy for amyotrophic lateral sclerosis.

Federici T, Boulis NM.

Neurobiol Dis. 2012 Nov;48(2):236-42. doi: 10.1016/j.nbd.2011.08.018. Epub 2011 Aug 25. Review.

PMID:
21889591
50.

Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.

Kliem MA, Heeke BL, Franz CK, Radovitskiy I, Raore B, Barrow E, Snyder BR, Federici T, Kaye Spratt S, Boulis NM.

Amyotroph Lateral Scler. 2011 Sep;12(5):331-9. doi: 10.3109/17482968.2011.574142. Epub 2011 Aug 24.

PMID:
21864053

Supplemental Content

Loading ...
Support Center